It was a pleasure to speak with Sarah Van Tassel (Weill Cornell Medicine, NY, USA) on her thoughts about the new therapeutic options for glaucoma management and the promising new combinations on the horizon.
- How has the pharmaceutical landscape for glaucoma developed in the last year? (00:12)
- Where do rho-kinase inhibitors sit in the treatment paradigm for glaucoma? (02:17)
- What promising new drugs and combinations are in the pipeline? (03:46)
Speaker Disclosure: Sarah Van Tassel has received speaker’s fees from the following: Aerie, Allergan, Zeiss, New World Medical, Equinox Ophthalmic.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of Kiaweh Eye 2021.
Share this Video
Related Videos In Glaucoma
Ticiana De Francesco, AGS 2023: Corneal endothelial cell safety profile of three different MiGS stents
Endothelial cell safety is an important factor to consider when selecting early surgical treatment for glaucoma patients. It was a pleasure to speak with Dr Ticiana De Francesco (Hospital de Olhos Leiria de Andrade (HOLA) Fortaleza, Brazil) around her study on comparing the effect of cataract surgery and iStent inject, Hydrus micro-stent, or CyPass micro-stent […]
Ticiana De Francesco, AGS 2023: Minimally invasive glaucoma surgery (MiGS) devices in glaucoma management
Minimally invasive glaucoma surgery (MiGS) devices have revolutionised in glaucoma management, achieving reliable IOP reduction with a favorable safety profile and quick postoperative recovery. It was a pleasure to speak with Dr Ticiana De Francesco (Hospital de Olhos Leiria de Andrade (HOLA) Fortaleza, Brazil) to find out her thoughts in the current status of minimally invasive glaucoma […]
Luis Abegão Pinto: World Glaucoma Week 2023
World Glaucoma Week kicks off on 12 March, 2023, with the aim of raising awareness of the impact of this devastating disease. The key to preventing needless vision impairment is prompt diagnosis and treatment. However, many are unaware they have the disease or do not have access to much-needed care. This is particularly true in […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!